Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB)
Tóm tắt
Từ khóa
Tài liệu tham khảo
Tomlinson BE, Blessed G, Roth M. Observations on the brains of demented old people. J Neurol Sci 1970;11:205-242.
McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
Roman GC, Tatemich ITK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN international workshop. Neurology 1993;43:240-260.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 4th ed. Washington DC: American Psychiatric Association 1994.
World Health Organisation. The ICD-10 classification of mental and behavioural disorders. Geneva: WHO 1992.
Kosaka K, Yoshimura M, Ikeda K, et al. Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree-a new disease? Clin Neuropathol 1984;3:185-192.
Perry RH Irving D Blessed G et al. Senile dementia of Lewy body type. A clinically and neuropathologically distinct type of Lewy body dementia in the elderly. J Neurol Sci 95:119-139.
Harrington CR, Wischik CM, Hurt J, et al. Senile dementia of Lewy body type and Alzheimer type are biochemically distinct in terms of paired helical filaments and hyperphosphorylated tau proteins. Dementia 1994;5:215-228.
Ditter SM, Mirra SS. Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients. Neurology 1987;37:754-760.
Byrne EJ, Lennox G, Godwin Austen RB, et al. (Nottingham Group for the study of Neurodegenerative Disorders). Diagnostic criteria for dementia associated with cortical Lewy bodies. Dementia 1991;2:283-284.
McKeith IG, Perry RH, Fairbairn AF, et al. Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med 1992;22:911-922.
Perry EK, Haroutunian V, Davis KL, et al. Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease. Neuro Report 1994;5:747-749.
Sahgal A, Galloway PH, McKeith IG, et al. A comparative study of attentional deficits in senile dementias of Alzheimer and Lewy body types. Dementia 1992;3:350-354.
Salmon DP Galasko D. Neuropsychological aspects of Lewy body dementia. In: Perry RH McKeith IG Perry EK Dementia with Lewy bodies. New York: eds. Cambridge University Press 1996:99-113.
Ballard C Harrison RWS Lowery K McKeith IG. Noncognitive symptoms in Lewy body dementia. In: Perry RH McKeith IG Perry EK eds. Dementia with Lewy bodies. New York: Cambridge University Press 1996:67-84.
McKeith IG Fairbairn AF Harrison RS. The management of the non-cognitive symptoms of Lewy body dementia. In: Perry RH McKeith IG Perry EK eds. Dementia with Lewy bodies. New York: Cambridge University Press 1996:381-396.
Galasko D, Hansen LA. Lewy body disease. Curr Opin Neurol Neurosurg 1992;5:889-894.
McKeith IG, Fairbairn AF, Bothwell RA, et al. An evaluation of the predictive validity and inter-rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type. Neurology 1994;44:872-877.
Forstl H, Burns A, Levy R, et al. The Lewy-Body variant of Alzheimer's disease. Clinical and pathological findings. BJ Psychiatry 1993;162:385-392.
McKeith IG. Lewy body disease. Curr Opin Psychiatry 1995;8:252-257.
Galasko D, Saitoh T, Xia T, et al. The apolipoprotein E allele epsilon 4 is over-represented in patients with the Lewy body variant of Alzheimer's disease. Neurology 1995;44:1950-1951.
Saitoh T, Xia Y, Chen X, et al. The CYP2D6B mutant allele is over-represented in the Lewy body variant of Alzheimer's disease. Ann Neurol 1995;37:110-112.
Marder K, Maestre G, Cote L, et al. The apoliprotein epsilon 4 allele in Parkinson's disease with and without dementia. Neurology 1996;44:1330-1331.
Armstrong M, Daly AK, Cholerton S, et al. Mutant debrisoquine hydroxylation genes in Parkinson's disease. Lancet 1992;339:1017-1018.
Dale GE, Probst A, Luthert P, et al. Relationships between Lewy bodies and pale bodies in Parkinson's disease. Acta Neuropathol (Berl) 1992;83:525-529.
Braak H Braak E Yilmazer D et al. Nigral and extranigral pathology in Parkinson's disease. J Neural Transm 1995;46(suppl):15-31.
Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardisation of the neuropathologic assessment for Alzheimer's disease. Neurology 1991;41:479-486.
Hansen LA, Masliah E, Galasko D, et al. Plaque only Alzheimer disease is usually the Lewy body variant, and vice versa. J Neuropathol Exp Neurol 1993;52:648-654.
Braak H, Braak E. Neuropathological staging of Alzheimer related changes. Acta Neuropathol (Berl) 1991;82:239-259.
Perry RH. Coronal map of Brodmann areas in the human brain. In: Roberts GW Leigh PN eds. Neuropsychiatric disorders. London: Wolfe 1993:1-10.
Kosaka K, Iseki E, Odawara T, et al. Cerebral type of Lewy body disease - a case report. Neuropathology 1994;16:72-75.
Langlais PJ, Thal L, Hansen LA. Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without Lewy bodies. Neurology 1993;43:1927-1934.
Perry EK, Irving D, Kerwin JM, et al. Cholinergic transmitter and neurotrophic activities in Lewy body dementia: similarity to Parkinson's and distinctions from Alzheimer's disease. Alzheimer Dis Assoc Disord 1993;7:69-79.
Perry EK, Marshall EF, Perry RH, et al. Cholinergic and dopaminergic activities in senile dementia of Lewy body type. Alzheimer Dis Assoc Disord 1990;4:87-95.
Piggott M Perry EK Marshall EF et al. Nigrostriatal dopaminergic activities in Lewy body dementia in relation to neuroleptic sensitivity: comparison with Parkinson's disease. Biol Psychiatry 1996 (in press).